TiffanyElisseSchwasinger-SchmidtMDPhD

Internal Medicine • Wichita, KS

Preventive Medicine, Obesity Medicine & Nutrition

Associate Professor of Medicine Director for the Center for Clinical Research

Join to view full profile

Dr. Schwasinger-Schmidt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schwasinger-Schmidt's full profile

Already have an account?

Office
1010 N Kansas St
Ste 3049
Wichita, KS 67214
Phone+1 316-293-2665

Fax+1 316-293-2657
Is this information wrong?

Summary

I am board certified in Internal Medicine. I completed my training and residency at KU School of Medicine-Wichita. I currently serve as an Associate Professor of Medicine and the Director of the Center for Clinical Research. I have a general Internal Medicine practice at the KU Midtown Clinic and am actively engaged in clinical trials research.

Education & Training

University of Kansas (Wichita)Residency, Internal Medicine, 2014 - 2017
University of Kansas School of MedicineClass of 2014
University of Nebraska-LincolnPhD, Genetics, Genomics and Bioinformatics, 2006 - 2010

Certifications & Licensure

KS State Medical License 2017 - 2024
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Excellence in Healthcare Award Wichita Business Journal, 2022
Early Career Achievement in Medicine Alumni Award University of Kansas School of Medicine, 2022
Women Who Lead Healthcare Award Wichita Business Journal, 2021
Emerging Leaders in Wichita Program Awardee Wichita Business Journal, 2021
40 under 40 Wichita Business Journal, 2021
Wichita Business Journal Innovation Award Wichita Business Journal, 2021
Faculty Investigator Research Award University of Kansas Medical Center, 2020
Healthcare Hero Award in Healthcare Education Wichita Business Journal, 2020
Early Career Physician of the Year American College of Physicians Kansas Chapter, 2019
Resident Poster Young Investigator Award American Association of Clinical Endocrinologists, 2017
Resident Travel Grant Award American Association of Clinical Endocrinologists, 2017
Young Investigator Award National Lipid Association, 2009
Join now to see all

Clinical Trials

TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
Therapy in Amyotrophic Lateral Sclerosis (TAME) Start of enrollment: 2018 Nov 07
Completed
Phase 2
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Start of enrollment: 2015 Sep 01
Completed
Phase 2
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression Start of enrollment: 2016 Jun 09
Completed
Phase 3
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD Start of enrollment: 2017 May 01
Completed
Phase 4
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_ Start of enrollment: 2016 Dec 29
Active, not recruiting
Phase 3
ACTIV-6: COVID-19 Study of Repurposed Medications Start of enrollment: 2021 Jun 08
Active, not recruiting
Phase 3
Escitalopram for Agitation in Alzheimer's Disease Start of enrollment: 2018 Jan 03
Active, not recruiting
Phase 3
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation Start of enrollment: 2021 Jun 17
Enrolling by invitation
Phase 3
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Start of enrollment: 2022 Sep 06
Recruiting
Phase 3
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression Start of enrollment: 2020 Nov 20
Completed
Phase 2
A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine Start of enrollment: 2021 Mar 24
Completed
Phase 3
Metformin in Alzheimer's Dementia Prevention Start of enrollment: 2021 Mar 22
Recruiting
Phase 2, Phase 3
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Start of enrollment: 2022 Dec 16
Active, not recruiting
Phase 2, Phase 3
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection Start of enrollment: 2023 Jun 09
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
Boulware DR, Lindsell CJ, Stewart TG, Hernandez AF, Collins S, McCarthy MW, Jayaweera D, Gentile N, Castro M, Sulkowski M, McTigue K, Felker GM, Ginde AA, Dunsmore SE,...> ;The New England journal of medicine.
Risk of COVID-19 after natural infection or vaccination.
Rick AM, Laurens MB, Huang Y, Yu C, Martin TCS, Rodriguez CA, Rostad CA, Maboa RM, Baden LR, El Sahly HM, Grinsztejn B, Gray GE, Gay CL, Gilbert PB, Janes HE, Kublin J...> ;EBioMedicine. 2023-09-20
A Piece of My Heart.
Tiffany Schwasinger-Schmidt> ;Journal of General Internal Medicine. 2023 Nov 1
Prevalence of elevated alkaline phosphatase levels among post-bariatric surgery patients.
Claudius Ciecko, Hayrettin Okut, Brent Lancaster, Tiffany Schwasinger-Schmidt> ;Langenbeck's Archives of Surgery. 2023 Jul 21
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Cli...
Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, ...> ;JAMA network open. 2023-07-03
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
McCarthy MW, Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Felker GM, Jayaweera D, Sulkowski M, Gentile N, Bramante C, Singh U, Dolor RJ, Ruiz-Unger J, Wilson S, DeL...> ;JAMA.
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, Collins S, McCarthy MW, Jayaweera D, Castro M, Sulkowski M, McTigue K, Thicklin F, Felker GM, Ginde AA, Bram...> ;JAMA.
1 citations
Acceptability and Preliminary Effectiveness of a Remote Dementia Educational Training Among Primary Care Providers and Health Navigators.
Jaime Perales-Puchalt, Ryan Townley, Michelle Niedens, Eric D Vidoni, K Allen Greiner, Tahira Zufer, Tiffany Schwasinger-Schmidt, Jerrihlyn L McGee, Hector Arreaza, Je...> ;Journal of Alzheimer's Disease. 2022 Jan 1
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Slandzicki AJ, Lim SC, Cohen J, Kavtaradze D, Amon AP, Gabriel A, Gentile N, Felker GM, Jayaweera D, McCarthy MW, Sulko...> ;JAMA. 2023-02-20
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah ...> ;JAMA network open. 2023-01-03
Reverse Engineering Drugs: Lorcaserin as an Example.
Tiffany Schwasinger-Schmidt, Sheldon H Preskorn> ;Advances in Neurobiology. 2023 Jan 1
Discovery of New Transmitter Systems and Hence New Drug Targets.
Tiffany Schwasinger-Schmidt, Sheldon H Preskorn> ;Advances in Neurobiology. 2023 Jan 1
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A...> ;The New England journal of medicine. 2021-09-29
1 citations
Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease.
Bobbie Paull-Forney, Hayrettin Okut, Tiffany E Schwasinger-Schmidt, Kirkpatrick, K., Kennedy Kirkpatrick> ;Kansas Journal of Medicine. 2021 Sep 1
2 citations
Bariatric Surgery Improves Renal Function in Patients With Obesity.
Oaklee L Abernathy, Hayrettin Okut, Bobbie Paull-Forney, Tiffany E Schwasinger-Schmidt> ;Cureus. 2021 Aug 26
1 citations
The State of Obesity in Kansas: A Community Based Approach to Chronic Care Management.
Morgan P Bretches, Tiffany E Schwasinger-Schmidt> ;Kansas Journal of Medicine. 2021 Jan 21
Impact of a Community-Based Weight Loss Program on Renal Function.
Tiffany E Schwasinger-Schmidt, Georges Elhomsy, Bobbie Paull-Forney> ;Cureus. 2020 May 13
Other Antidepressants.
Schwasinger-Schmidt, T. E.,Macaluso, M.> ;Handb Exp Pharmacol. 2018 Sep 09
1 citations
The State of Diabetes in Kansas: A Community Centered Approach to the Treatment of Diverse Populations.
Tiffany E Schwasinger-Schmidt, Jon Schrage, Justin B. Moore, Betty M. Drees> ;Kansas Journal of Medicine. 2019 Jan 15
29 citations
Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Tiffany E Schwasinger-Schmidt, David C. Robbins, S. Janette Williams, Lesya Novikova, Lisa Stehno-Bittel> ;Pharmacological Research. 2013 Oct 1
12 citations
Diffusion into human islets is limited to molecules below 10 kDa
S.J. Williams, Tiffany E Schwasinger-Schmidt, D. Zamierowski, Lisa Stehno-Bittel> ;Tissue & Cell. 2012 Oct 1
35 citations
Evolution of starvation resistance in Drosophila melanogaster: measurement of direct and correlated responses to artificial selection.
Tiffany E Schwasinger-Schmidt, Stephen D. Kachman, Lawrence G. Harshman> ;Journal of Evolutionary Biology. 2012 Feb 1
Join now to see all

Journal Articles

Impact of a Community-Based Weight Loss Program on Renal Function
Tiffany E. Schwasinger-Schmidt, Georges Elhomsy, Bobbie Paull-Forney, Cereus, 5/13/2020

Authored Content

Inhaled fluticasone furoate for outpatient treatment of covid-19September 2023

Press Mentions

US Research Centre Uses New Methods to Include Rural People in TrialsMay 5th, 2023
Ivermectin Shown Ineffective in Treating COVID-19, According to Multi-Site Study Including KU Medical CenterDecember 1st, 2022
Local Doctors Concerned About COVID-19 Case Surge from New Year’s CelebrationsDecember 30th, 2021
Join now to see all